Word

HCI

Status

Registered

Status Code

700

Status Date

Tuesday, May 2, 2023

Serial Number

97169341

Registration Number

7040282

Registration Date

Tuesday, May 2, 2023

Mark Type

4000

Filing Date

Monday, December 13, 2021

Published for Opposition

Tuesday, February 14, 2023

Trademark Owner History

HYBRID CONCEPTS INTERNATIONAL, LLC - Original Registrant

Classifications

36 Financial consulting services, namely, advising others regarding intellectual property investments; Investment consultation in the fields of product, technical, regulatory, preclinical, clinical, and commercial diligence for innovative potential or investigational medical products

35 Assistance, advisory services and consultancy with regard to business planning; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval; Business consulting services; Business consulting services in the field of potential medical cures including cell and gene therapies; Business consultation in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, chemistry, manufacturing and controls, and quality assurance/quality control; Business consulting services, namely, providing assistance in development of business strategies and creative ideation; Business management consulting and advisory services; Business support services, namely, business consulting to freelancers, start-ups, existing businesses and non-profit organizations; Consultancy and advisory services in the field of business strategy; Consulting services in the field of medical product approval for commercial purposes; International business consulting services relating to USA and outside of USA product, clinical and commercial development of investigational or approved medical products; New business venture development and formation consulting services; Promoting the exchange of information and resources within the scientific research communities to achieve advances in the field of 21st century transformational science; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Providing independent review of clinical trials for business purposes; Promoting technical and scientific investigation, research and experimentation in the field of scientific discovery through support of educational institutions and scientific organizations

44 Consulting services in the field of health; Consulting services to health care providers in the field of treating life-changing or life-threatening diseases

42 Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Medical and scientific research information in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, regulatory affairs including preclinical, clinical and commercial stage, pharmaceutical preclinical and clinical research, development, manufacturing/CMC and quality assurance/quality control; Providing information about medical and scientific research; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific and technological services, namely, scientific research in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research consulting in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Scientific research and development; Technological planning and consulting services in the field of cell therapy, gene therapy, gene editing, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, medical devices, scientific research for preclinical, clinical and commercial stage pharmaceuticals, pharmaceutical preclinical and clinical research, development, and quality assurance/quality control; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific consulting and research services relating to foods and dietary supplements; Scientific research consulting in the field of cosmetics

HYBRID CONCEPTS INTERNATIONAL

Trademark Events

May 2, 2023

Notice Of Registration Confirmation Emailed

May 2, 2023

Registered-Principal Register

Feb 14, 2023

Official Gazette Publication Confirmation E-Mailed

Feb 14, 2023

Published For Opposition

Jan 25, 2023

Notification Of Notice Of Publication E-Mailed

Jan 9, 2023

Approved For Pub - Principal Register

Dec 28, 2022

Teas/Email Correspondence Entered

Dec 27, 2022

Correspondence Received In Law Office

Dec 27, 2022

Teas Response To Office Action Received

Nov 17, 2022

Notification Of Non-Final Action E-Mailed

Nov 17, 2022

Non-Final Action E-Mailed

Nov 17, 2022

Non-Final Action Written

Nov 11, 2022

Previous Allowance Count Withdrawn

Oct 4, 2022

Withdrawn From Pub - Og Review Query

Sep 20, 2022

Approved For Pub - Principal Register

Sep 19, 2022

Assigned To Examiner

Dec 16, 2021

New Application Office Supplied Data Entered

Dec 16, 2021

New Application Entered